Neuromuscular Electric Stimulator Market – By Product Type, By Application, End Use & Forecast, 2024 – 2032

Neuromuscular Electric Stimulator Market Size

The global neuromuscular electric stimulator market size was valued at USD 381.7 million in 2023 and is expected to exhibit growth at a CAGR of 9.1% from 2024 – 2032 period. Factors such as technological advancements, an increase in cases related to the musculoskeletal system, and rise of demand related to rehabilitation are competitively increasing the global market.
 

These devices are being accepted in many sectors, such as sports medicine or physical therapy in which these devices are being used importantly. For instance, innovations like smart technology integrated with wearable sensors have improved patient outcomes and those of end users. Advancements geared toward personal portable neuromuscular stimulators are allowing the public to benefit from more precise treatments while receiving therapy in the comfort of their homes, which is again contributing toward market growth.
 

Furthermore, companies like Omron have introduced advanced models featuring wireless technology and customizable programs to cater to individual therapy needs. There is also increased market confidence due to endorsements and approvals from U.S. FDA and European Medicines Agency (EMA).
 

A neuromuscular electric stimulator (NMES) is a medical device that uses electrical impulses to stimulate muscle contractions. It is primarily used for muscle rehabilitation, strengthening, and pain management. NMES operates by delivering controlled electrical impulses to nerves, which induce muscle contractions like natural movements. This therapy is frequently employed in physical therapy to address muscle atrophy, enhance circulation, and support recovery following injury or surgery.

Neuromuscular Electric Stimulator Market Trends

The growing demand for non-invasive treatment options is a significant driver for the neuromuscular electric stimulator (NMES) market. NMES devices, remains preferred as it makes use of muscle stimulation without necessary surgical intervention, therefore making it an appealing option due to lack of associated risks and recovery times.
 

• Patients and healthcare providers are increasingly opting for NMES as an alternative to pharmaceuticals, especially in pain and muscle recovery, to avoid dependency or side effects that are likely to arise with medications.
   
• According to the American Physical Therapy Association (APTA), NMES is effective in increasing muscle and functional recovery in patients who are unable to exercise due to injury or post-surgery. In fact, NMES devices are included as standard equipment in sports medicine for the improvement of muscle recovery after surgery, injury healing, and muscle disuse atrophy prevention.
   
• Furthermore, a study published in the Journal of Orthopaedic & Sports Physical Therapy highlighted that NMES therapy notably reduced recovery time and improved muscle function in athletes recovering from anterior cruciate ligament (ACL) reconstruction.
   

Neuromuscular Electric Stimulator Market Analysis

Based on product type, the market is classified into handheld neuromuscular stimulators and wearable neuromuscular stimulators. The handheld neuromuscular stimulators segment generated the highest revenue of USD 309.8 million in 2023.
 

• The need for non-invasive therapies done at home is on the rise, due to the increase in patients suffering from excessive sports injuries and issues like arthritis. Handheld neuromuscular stimulators are preferred due to their convenience and ease of use compared to bulky stationary devices.
   
• Moreover, these systems are also made better and more appealing to patients and doctors by integration of Bluetooth connectivity and smartphone integration.
   

Based on application, the neuromuscular electric stimulator market is categorized into pain management, muscle rehabilitation, post-surgical recovery, and sports medicine. The pain management segment generated the highest revenue of USD 156 million in 2023.
 

• The demand for effective, non-invasive pain relief solutions has increased due to the rise in the prevalence of back pain, arthritis, and neuropathic pain. Neuromuscular electric stimulators use targeted management techniques, which employ the stimulation of nerves and muscles to alleviate pain and improve functionality without medication.  
   
• In addition, the progression of electric stimulation for pain relief is well known among health professionals and patients which aids in market growth. The creation of portable and easy-to-use devices is another advancement. These increase accessibility and convenience for patients.
   
• The focus on multi-dimensional approaches to pain management, along with positive regulations and clinical support, fuels the growth of the segment.

Based on end use, the neuromuscular electric stimulator market is segmented into hospitals, rehabilitation centers, home care settings, sports clinics, and ambulatory surgical centers. The hospitals segment dominated the market in 2023 and is anticipated to reach USD 321 million by the end of forecast period.
 

• Hospitals are the primary providers of healthcare services for musculoskeletal diseases as well as post-operative and recovery and rehabilitation where neuromuscular electric stimulators are widely used.
   
• The increasing number of patients with chronic ailments such as stroke, Multiple Sclerosis (MS), and spinal cord injury has heightened the need for rehabilitation solutions, leading hospitals to adopt these devices for effective patient care.
   
• In addition, hospitals possess the latest equipment and trained personnel which justifies the application of some advanced types of neuromuscular stimulators, which are often beyond the scope of general practice. The increase in the number of surgeries and greater emphasis on recovery after surgery has increased the need for such units.

North America neuromuscular electric stimulator market accounted for USD 157.3 million market revenue in 2023 and is anticipated to grow at a CAGR of 8.4% between 2024 – 2032 period.
 

• The region is a key player due to its well-established healthcare infrastructure and extensive understanding of physical therapy solutions. The demand for neuromuscular stimulators has increased with the rising number of musculoskeletal problems like arthritis, spinal cord injury, and stroke in the region. For instance, the Stroke Awareness Foundation reports that approximately 795,000 people suffer a stroke in the U.S. every year, demonstrating the need for neuromuscular stimulator devices for proper muscle re-education and recovery.
   
• Demand continues to grow for the treatment especially when it comes to professional athletes or fitness enthusiasts who appreciate the value of sports medicine and fitness rehabilitation. The increasing awareness of sports-related injuries and their treatment options, such as neuromuscular stimulation, has seen common adoption across clinics and training centers in North America.
   

U.S. neuromuscular electric stimulator market accounted for USD 146.4 million market revenue in 2023 and is estimated to hold substantial growth between 2024 – 2032 period.
 

• A significant trend is the increasing use of NMES devices in clinical as well as home settings. The use of NMES in hospitals and rehabilitation centers is on the rise because of their efficiency in pain relieving and recovery from operations. For example, in orthopedic rehabilitation, NMES devices are employed to minimize muscle damage after surgeries like total arthroplasty of the knee, and to expedite recovery.
   
• These devices are preferred by many healthcare providers owing to clinical research documenting the effectiveness of NMES in muscle strength amplification, reduction of rehabilitation time, and subsequent increase in productivity.

UK neuromuscular electric stimulator market is projected to grow remarkably in the coming years.
 

• Treating patients associated with chronic diseases is stimulating the adoption of NMES more widely in home care. There is a shift in the European healthcare system toward the home care model to minimize the number of patient hospitalizations and healthcare costs. With the design of NMES devices changing to simpler and more portable mechanisms, more patients can access them for home use.
   
• Moreover, this trend can also be seen in the growing market for more affordable NMES devices that are user-friendly and meant for self-treatment by patients suffering from chronic pain, muscle atrophy, and patients with long-term rehabilitation needs.
   

Japan holds a dominant position in the Asia Pacific neuromuscular electric stimulator market.
 

• The growing prevalence of musculoskeletal disorders, rising geriatric population, and the increasing adoption of advanced rehabilitation therapies are among key factors fueling the industry growth.
   
• Non-invasive neuromuscular electric stimulators are used as an adjuvant pain management therapy that allows muscle contraction without the use of medications. For example, Oxford University Press reported in a nationwide survey in Japan that around 822,000 people are diagnosed with rheumatoid arthritis and the highest prevalence is found between the ages of 65 to 85 years.
   

Neuromuscular Electric Stimulator Market Share

Market leaders control a large share of the global market. The market is dynamic as important players, marginal players, and new entrants are participating in the competition. Some of the larger companies such as OMRON Corporation, Enovis Corporation, and Ottobock are well-established with their large product range comprising of neuromuscular electric stimulator, handheld neuromuscular stimulators, wearable neuromuscular stimulators, and new technologies and they have a worldwide market.
 

Neuromuscular Electric Stimulator Market Companies

Prominent players operating in the neuromuscular electric stimulator industry include:

• AxioBionics LLC
• Enovis Corporation
• Ibramed Medical
• MTR + Vertriebs GmbH
• NeuroMetrix, Inc.
• OMRON Corporation
• Ottobock
• RS Medical
• Sky Medical Technology Ltd.
• Verity Medical Ltd.
• Zynex, Inc.
   
• Specialized in custom-designed wearable electrical stimulation solutions for pain management and rehabilitation.
   
• Strong focus on patient-specific applications, addressing unique medical needs.
   
• Integration of advanced technology with user-centered design for long-term therapeutic use.
   
• Established infrastructure supporting direct-to-patient delivery and efficient distribution.
   

Neuromuscular Electric Stimulator Industry News:

• In July 2024, Firstkind Ltd. a subsidiary of Sky Medical Technology Ltd, announced accreditation of its geko device Wound Therapy user training programme by the Royal College of Nursing (RCN) Centre for Professional Accreditation. This collaboration aims to expand the market positioning of the company and reach a broader customer base
   
• In March 2024, NeuroMetrix, Inc. announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic commercial launch in December 2022. This achievement enabled the company to solidify its leading position in the market and expand its customer base.
   

The neuromuscular electric stimulator market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Handheld neuromuscular stimulators
• Wearable neuromuscular stimulators

Market, By Application

• Pain management
• Muscle rehabilitation
• Post-surgical recovery
  • Knee replacement recovery
  • Hip replacement recovery
  • Ankle replacement recovery
• Sports medicine

Market, By End Use

• Hospitals
• Rehabilitation centers
• Home care settings
• Sports clinics
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa